Comparison of prophylactic effect of UGIB and effects on platelet function between PPIs and H₂RAs combined with DAPT: systematic review and meta-analysis

References

• WangYPanYZhaoXCHANCE InvestigatorsClopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomesCirculation20151321404625957224
   PubMed Web of Science ®Google Scholar
• WangXZhaoXJohnstonSCCHANCE investigatorsEffect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudyNeurology201585757357926283758
   PubMed Web of Science ®Google Scholar
• MorneauKMReavesABMartinJBOliphantCSAnalysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrelJ Manag Care Pharm201420218719324456320
   PubMed Web of Science ®Google Scholar
• Schjerning OlsenAMLindhardsenJGislasonGHImpact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide studyBMJ2015351h509626481405
   PubMed Web of Science ®Google Scholar
• HeYChanEWManKKDosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort studyDrug Saf201437971172125096957
   PubMed Web of Science ®Google Scholar
• WeiszGSmilowitzNRKirtaneAJProton pump inhibitors, platelet reactivity, and cardiovascular outcomes after drug-eluting stents in clopidogrel-treated patients: the ADAPT-DES studyCirc Cardiovasc Interv2015810e00195226458411
   PubMed Web of Science ®Google Scholar
• YamaneKKatoYTazakiJEffects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapyJ Atheroscler Thromb201219655956922472213
   PubMed Web of Science ®Google Scholar
• SimonNFinziJCaylaGMontalescotGColletJPHulotJSOmeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patientsEur J Clin Pharmacol20157191059106626071277
   PubMed Web of Science ®Google Scholar
• YasuTSatoNKurokawaYSaitoSShojiMEfficacy of H2 receptor antagonists for prevention of upper gastrointestinal bleeding during dual-antiplatelet therapyInt J Clin Pharmacol Ther2013511185486024040853
   PubMed Web of Science ®Google Scholar
• HigginsJPTGreenSChapter 8: Assessing risk of bias in included studiesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]The Cochrane Collaboration2011 Available from: www.handbook.cochrane.orgAccessed November 10, 2016
   Google Scholar
• WellsGASheaBO’ConnellDThe Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspAccessed November 10, 2016
   Google Scholar
• HigginsJPTDeeksJJAltmanDGChapter 16: Special topics in statisticsHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]The Cochrane Collaboration2011 Available from: http://www.cochrane-handbook.org
   Google Scholar
• ArbelYBiratiEYFinkelsteinAPlatelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover studyClin Cardiol201336634234623630016
   PubMed Web of Science ®Google Scholar
• FurtadoRHGiuglianoRPStrunzCMDrug interaction between clopidogrel and ranitidine or omeprazole in stable coronary artery disease: a double-blind, double dummy, randomized studyAm J Cardiovasc Drugs201616427528427289472
   PubMed Web of Science ®Google Scholar
• MoceriPDoyenDCerboniPFerrariEDoubling the dose of clopidogrel restores the loss of antiplatelet effect induced by esomeprazoleThromb Res2011128545846221777954
   PubMed Web of Science ®Google Scholar
• NgFHTunggalPChuWMEsomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarctionAm J Gastroenterol2012107338939622108447
   PubMed Web of Science ®Google Scholar
• ParriMSGianettiJDushpanovaAPantoprazole significantly interferes with antiplatelet effect of clopidogrel: results of a pilot randomized trialInt J Cardiol201316752177218122727972
   PubMed Web of Science ®Google Scholar
• TunggalPNgFHLamKFChanFKLauYKEffect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trialAm Heart J2011162587087422093203
   PubMed Web of Science ®Google Scholar
• UotaniTSugimotoMIchikawaHComparison of preventive effects of rabeprazole and famotidine on gastric mucosal injury induced by dual therapy with low-dose aspirin and clopidogrel in relation to CYP2C19 genotypes and H Pylori infectionGastroenterology20131445 Suppl 1S478S479
   PubMed Web of Science ®Google Scholar
• YanoHTsukaharaKMoritaSInfluence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter studyCirc J201276112673268022864179
   PubMed Web of Science ®Google Scholar
• Cappelletti GalanteMGarcia SantosVBezerra da CunhaGWAssessment of the use of clopidogrel associated with gastroprotective medications in outpatientsFarm Hosp201236421621922115860
   PubMedGoogle Scholar
• MacaioneFMontainaCEvolaSNovoGNovoSImpact of dual antiplatelet therapy with proton pump inhibitors on the outcome of patients with acute coronary syndrome undergoing drug-eluting stent implantationISRN Cardiol2012201269276122792485
   PubMedGoogle Scholar
• NgFHLamKFWongSYUpper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapyDigestion2008773–417317718577887
   PubMed Web of Science ®Google Scholar
• YewMSYeoPSDOngJLPOmeprazole use is associated with increased cardiovascular complications in Asian patients on aspirin and clopidogrel after percutaneous coronary interventionJACC Cardiovasc Interv201472S17S18
   Google Scholar
• MoCSunGLuMLProton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuriesWorld J Gastroenterol201521175382539225954113
   PubMed Web of Science ®Google Scholar
• CardosoRNBenjoAMDiNicolantonioJJIncidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysisOpen Heart201521e00024826196021
   PubMed Web of Science ®Google Scholar
• YasudaHYamadaMSawadaSUpper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stentingIntern Med200948191725173019797827
   PubMed Web of Science ®Google Scholar
• DouglasIJEvansSJHingoraniADClopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designsBMJ2012345e438822782731
   PubMed Web of Science ®Google Scholar
• MelloniCWashamJBJonesWSConflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic reviewCirc Cardiovasc Qual Outcomes201581475525587094
   PubMed Web of Science ®Google Scholar
• FocksJJBrouwerMAvan OijenMGLanasABhattDLVerheugtFWConcomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome- a systematic reviewHeart201399852052722851683
   PubMed Web of Science ®Google Scholar
• GargiuloGCostaFAriottiSImpact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trialAm Heart J20161749510226995375
   PubMed Web of Science ®Google Scholar
• ValgimigliMCampoGMontiMProlonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) InvestigatorsShort- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trialCirculation2012125162015202622438530
   PubMed Web of Science ®Google Scholar
• CampoGTebaldiMVranckxPShort- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia)J Am Coll Cardiol201463650651224161321
   PubMed Web of Science ®Google Scholar
• NorgardNBMathewsKDWallGCDrug-drug interaction between clopidogrel and proton pump inhibitorsAnn Pharmacother20094371266127419470853
   PubMed Web of Science ®Google Scholar
• FoodUSAdministrationDrugFDA reminder to avoid concomitant use of Plavix (clopidogrel) and omeprazole Available from: www.fda.gov/Drugs/DrugSafety/ucm231161.htmAccessed November 10, 2016
   Google Scholar
• BhattDLScheimanJAbrahamNSAmerican College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsCirculation2008118181894190918836135
   PubMed Web of Science ®Google Scholar
• AbrahamNSHlatkyMAAntmanEMACCF/ACG/AHAACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID useAm J Gastroenterol2010105122533254921131924
   PubMed Web of Science ®Google Scholar
• TanHJMahadevaSMenonJStatements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleedingJ Dig Dis201314111023134105
   PubMed Web of Science ®Google Scholar